ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1458

Systemic Lupus Erythematosus (SLE) Patients with Cognitive Impairment Experience More Fatigue Compared to Patients Without Impairment

Delansie Lawrence1, Jiandong Su1, Andrea Knight2, Kathleen Bingham3, Mahta Kakvan1, Maria Carmela Tartaglia4, Leslet Ruttan5, Joan Wither6, May Choi7, Simone Appenzeller8, Nicole Anderson1, Dennisse Bonilla1, Patricia Katz9, Dorcas Beaton10, Robin Green5, Zahi Touma1 and Michelle Barraclough11, 1Schroeder Arthritis Institute, Krembil Research Institute, University Health Network and University of Toronto, Toronto, ON, Canada, 2The Hospital for Sick Children, Division of Rheumatology, Department of Paediatrics, University of Toronto, Toronto, ON, Canada, 3Centre for Mental Health, University Health Network; Department of Psychiatry, University of Toronto, Toronto, ON, Canada, 4University of Toronto Krembil Neurosciences Centre, Toronto, ON, Canada, 5University Health Network-Toronto Rehabilitation Institute, Toronto, ON, Canada, 6Schroeder Arthritis Institute, Krembil Research Institute, University Health Network, University of Toronto, Toronto, ON, Canada, 7Brigham and Women's Hospital | University of Calgary, Calgary, AB, Canada, 8Unicamp, Campinas, São Paulo, Brazil, 9UCSF, San Rafael, CA, 10Institute for Work & Health, Toronto, ON, Canada, 11Schroeder Arthritis Institute, Krembil Research Institute, University Health Network, University of Toronto, Centre for Epidemiology Versus Arthritis, Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Toronto, ON, Canada

Meeting: ACR Convergence 2022

Keywords: Cognitive dysfunction, Fatigue, Neuropsychological Assessment, Patient reported outcomes

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2022

Title: SLE – Diagnosis, Manifestations, and Outcomes Poster II: Manifestations

Session Type: Poster Session C

Session Time: 1:00PM-3:00PM

Background/Purpose: Cognitive impairment (CI) is highly prevalent in patients with systemic lupus erythematosus (SLE). Objective prevalence rates are reported as 38% [range: 20% to 80%] and subjective even higher. Additionally, SLE patients frequently identify fatigue as a component of their clinical syndrome. Studies have shown that SLE patients with CI may experience more cognitive fatigue. Therefore, we hypothesized that patients with subjective CI will report more fatigue compared to patients without subjective CI.

Methods: Data on 228 consecutive consenting SLE patients (18 – 65 years old) attending a single centre between July 2018 to July 2020 was analysed. Three PROMIS-CAT (Patient reported outcomes measurement information system – computerized adaptive tests) questionnaires were applied:

– PROMIS Bank v 1.0- Fatigue
– PROMIS Item Bank v 2.0- Cognitive function abilities sub-set
– PROMIS Item Bank v 2.0- Cognitive function general

Additionally, we administered the FACIT questionnaire, which is a 13-item tool that measures an individual’s level of fatigue using a 4-point Likert scale. Descriptive analyses were used to describe the patients’ characteristics. We studied the association between subjective CI and fatigue measures using a Pearson correlation coefficient matrix. The association between subjective CI (PROMIS cognitive function general) and fatigue (FACIT) was further assessed using univariable and multivariable linear regression analyses, with clinical relevant variables, sex, ethnicity and immunosuppressant use included.

Results: Among the 228 participants, 89.5% were females with a mean age of 47.9 ± 14.0 years. The mean disease duration was 18.4 ± 12.3 years (Table 1).

The mean score for PROMIS Fatigue was 57.3±10.6 and the mean scores for PROMIS cognitive abilities and cognitive general were 47.0±9.4 and 46.6±8.9, respectively (indicating that both fatigue and subjective CI is worse in our SLE cohort compared to the general population). Subjective CI function and fatigue correlated with each other, as patients with more subjective CI displayed more fatigue (Table 2). Multivariable regression analysis confirmed a negative relationship in which a higher PROMIS cognitive general score was associated with lower FACIT total score: adjusted parameter estimate -0.69 (95% confidence interval -0.80 to -0.57), p< 0.0001, (Table 3).

Conclusion: Our results showed that there is an association between subjective CI with higher fatigue levels when measured by the PROMIS Fatigue tool and the FACIT questionnaire. This information highlights how SLE affects both fatigue and subjective CI and that these aspects should be targeted in the multifaceted care of SLE patients.

Supporting image 1

Table 1. Patient characteristics at time of study

Supporting image 2

Table 2. Matrix table summarizing four correlations for cognition and fatigue (N = 228):
(Pearson correlation coefficient/p value)

Supporting image 3

Table 3. Multivariable linear regression result for variables associated with higher FACIT
total score with cognitive general scores as the main in-dependent variable


Disclosures: D. Lawrence, None; J. Su, None; A. Knight, None; K. Bingham, None; M. Kakvan, None; M. Tartaglia, None; L. Ruttan, None; J. Wither, AstraZeneca, Pfizer; M. Choi, AstraZeneca, MitogenDx, mallinckrodt, Janssen, AbbVie/Abbott, Alimentiv, Amgen, AVIR Pharma Inc, BioJAMP, Bristol-Myers Squibb(BMS), Celltrion, Ferring, Fresenius Kabi, McKesson, Mylan, Takeda, Pendopharm, Pfizer, Roche; S. Appenzeller, None; N. Anderson, None; D. Bonilla, None; P. Katz, None; D. Beaton, None; R. Green, None; Z. Touma, None; M. Barraclough, None.

To cite this abstract in AMA style:

Lawrence D, Su J, Knight A, Bingham K, Kakvan M, Tartaglia M, Ruttan L, Wither J, Choi M, Appenzeller S, Anderson N, Bonilla D, Katz P, Beaton D, Green R, Touma Z, Barraclough M. Systemic Lupus Erythematosus (SLE) Patients with Cognitive Impairment Experience More Fatigue Compared to Patients Without Impairment [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/systemic-lupus-erythematosus-sle-patients-with-cognitive-impairment-experience-more-fatigue-compared-to-patients-without-impairment/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/systemic-lupus-erythematosus-sle-patients-with-cognitive-impairment-experience-more-fatigue-compared-to-patients-without-impairment/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology